E
Emmanouil Karofylakis
Researcher at National and Kapodistrian University of Athens
Publications - 14
Citations - 233
Emmanouil Karofylakis is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 11 publications receiving 152 citations.
Papers
More filters
Journal ArticleDOI
Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study.
Shima Shahjouei,Soheil Naderi,Soheil Naderi,Jiang Li,Ayesha Khan,Durgesh Chaudhary,Ghasem Farahmand,Shailesh Male,Christoph J. Griessenauer,Mirna Sabra,Stefania Mondello,Achille Cernigliaro,Faezeh Khodadadi,Apoorva Dev,Nitin Goyal,Sakineh Ranji-Burachaloo,Oluwaseyi Olulana,Venkatesh Avula,Seyed Amir Ebrahimzadeh,Orkhan Alizada,Mehmet Hanci,Askar Ghorbani,Alaleh Vaghefi far,Annemarei Ranta,Annemarei Ranta,Martin Punter,Martin Punter,Mahtab Ramezani,Nima Ostadrahimi,Georgios Tsivgoulis,Georgios Tsivgoulis,Paraskevi C. Fragkou,Peyman Nowrouzi-Sohrabi,Emmanouil Karofylakis,Sotirios Tsiodras,Saeideh Neshin Aghayari Sheikh,Alia Saberi,Mika Niemelä,Behnam Rezai Jahromi,Ashkan Mowla,Mahsa Mashayekhi,Reza Bavarsad Shahripour,Seyed Aidin Sajedi,Mohammad Ghorbani,Arash Kia,Nasrin Rahimian,Vida Abedi,Vida Abedi,Ramin Zand,Ramin Zand +49 more
TL;DR: The results of this multi-national study on hospitalized patients with Sars-CoV-2 infection indicated an overall stroke risk of 0.5% and the need for mechanical ventilation and the history of ischaemic heart disease are the independent predictors of stroke among SARS-Cov-2 patients.
Journal ArticleDOI
Review of trials currently testing treatment and prevention of COVID-19.
Paraskevi C. Fragkou,Drifa Belhadi,Nathan Peiffer-Smadja,Charalampos D. Moschopoulos,François Xavier Lescure,Hannah Janocha,Emmanouil Karofylakis,Yazdan Yazdanpanah,F. Mentré,Chrysanthi Skevaki,Cédric Laouénan,Sotirios Tsiodras +11 more
TL;DR: All registered clinical trials examining treatment and prevention options for COVID-19 are summarized, including withdrawn or cancelled studies and trials not reporting therapeutic or preventative strategies for CO VID-19.
Journal ArticleDOI
Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19).
Georgios Tsivgoulis,Georgios Tsivgoulis,Paraskevi C. Fragkou,Alexander Delides,Emmanouil Karofylakis,Dimitra Dimopoulou,Petros P. Sfikakis,Sotirios Tsiodras +7 more
TL;DR: A pilot case-control study using objective assessment of olfactory function with a standardized microencapsulated odor identification test in patients diagnosed with COVID-19 using real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) from upper respiratory samples.
Journal ArticleDOI
Update in Viral Infections in the Intensive Care Unit
Paraskevi C. Fragkou,Charalampos D. Moschopoulos,Emmanouil Karofylakis,Theodoros Kelesidis,Sotirios Tsiodras +4 more
TL;DR: This work reviews the most updated data on epidemiology, common clinical features, diagnosis, pathogenesis, treatment and prevention of severe community- and hospital-acquired viral infections in the ICU settings.
Journal ArticleDOI
Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study.
Georgios Tsivgoulis,Paraskevi C. Fragkou,Emmanouil Karofylakis,Maria Paneta,Konstantinos A. Papathanasiou,Lina Palaiodimou,Constantin Psarros,Matilda Papathanasiou,Stefanos Lachanis,Petros P. Sfikakis,Sotirios Tsiodras +10 more
TL;DR: A recent prospective observational study by Lui et al. as mentioned in this paper found abnormal thyroid function tests, defined as deranged thyroid-stimulating hormone (TSH), free thyroxine (fT4) and/or free triiodothyronine (FT3), in 25 patients (13.1%), suggesting that SARS-CoV-2 might directly induce viral thyroiditis.